An assessment of the efficacy of atorvastatin in achieving LDL cholesterol target levels in patients with coronary heart disease: a general practice study.
Adherence to evidence-based guidelines for the secondary prevention of coronary heart disease (CHD) has been shown to be poor in a number of surveys. In this open-label, non-comparative 17-week trial, 399 patients with existing CHD and LDL cholesterol concentration > 3.4 mmol/l (130 mg/dl) we...
Main Authors: | Neil, H, Fowler, G, Patel, H, Eminton, Z, Maton, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1999
|
Similar Items
-
Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
by: Charlton-Menys, V, et al.
Published: (2009) -
Preliminary Pilot Study of Combined Effects of Physical Activity and Achievement of LDL-Cholesterol Target on Coronary Plaque Volume Changes in Patients with Acute Coronary Syndrome
by: Miho Nishitani-Yokoyama, et al.
Published: (2020-05-01) -
Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease
by: E. Sverre, et al.
Published: (2023-06-01) -
The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease
by: Hopewell, J, et al.
Published: (2012) -
LDL cholesterol targets--how low to go?
by: Bulbulia, R, et al.
Published: (2012)